Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
1q41 | Usher syndrome, type 2A | 276901 | AR | 3 | USH2A | 608400 |
10q24.31 | {Retinal disease in Usher syndrome type IIA, modifier of} | 276901 | AR | 3 | PDZD7 | 612971 |
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
5q14.3 | Usher syndrome, type 2C | 605472 | AR, DD | 3 | ADGRV1 | 602851 |
5q14.3 | Usher syndrome, type 2C, GPR98/PDZD7 digenic | 605472 | AR, DD | 3 | ADGRV1 | 602851 |
10q24.31 | Usher syndrome, type IIC, GPR98/PDZD7 digenic | 605472 | AR, DD | 3 | PDZD7 | 612971 |
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
9q32 | Deafness, autosomal recessive 31 | 607084 | AR | 3 |
Usher syndrome, type 2D | 611383 | AR | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
1q41 | Retinitis pigmentosa 39 | 613809 | AR | 3 |
Usher syndrome, type 2A | 276901 | AR | 3 |
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
9q32 | Usher syndrome, type 2D | 611383 | AR | 3 | WHRN | 607928 |
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
5q14.3 | ?Febrile seizures, familial, 4 | 604352 | AD | 3 |
Usher syndrome, type 2C | 605472 | AR, DD | 3 | |
Usher syndrome, type 2C, GPR98/PDZD7 digenic | 605472 | AR, DD | 3 |
|
|
|
|
|
|
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM